Avacta Group (LON:AVCT) Stock Passes Below 200-Day Moving Average – Here’s What Happened

Avacta Group Plc (LON:AVCT)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 60.26 and traded as low as GBX 51. Avacta Group shares last traded at GBX 53, with a volume of 1,381,569 shares traded.

Analyst Ratings Changes

Separately, Peel Hunt reaffirmed a “buy” rating and issued a GBX 99 price objective on shares of Avacta Group in a report on Monday, October 13th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Avacta Group has an average rating of “Buy” and a consensus price target of GBX 99.

Avacta Group Stock Up 4.2%

The stock has a market cap of £239.59 million, a price-to-earnings ratio of -3.15 and a beta of 1.12. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 52.53. The stock has a fifty day moving average of GBX 65.86 and a two-hundred day moving average of GBX 60.26.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).